Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Capricor Therapeutics
CAPR
$243M
| $350K | ﹤0.01% |
73,468
+59,989
| +445% | +$334K |
|
|
LNAI
3327
Lunai Bioworks
LNAI
$9.16M
| $348K | ﹤0.01% |
+2,487
| New | +$339K |
|
3328
SoundThinking
SSTI
$103M
| $347K | ﹤0.01% |
28,484
+2,561
| +10% | +$36.4K |
|
3329
NI Holdings
NODK
$314M
| $347K | ﹤0.01% |
22,654
| – | – |
|
3330
Smith-Midland
SMID
$151M
| $345K | ﹤0.01% |
+12,458
| New | +$456K |
|
|
SCPH
3331
DELISTED
scPharmaceuticals
SCPH
| $345K | ﹤0.01% |
79,202
+6,644
| +9% | +$29.2K |
|
3332
Taylor Devices
TAYD
$168M
| $342K | ﹤0.01% |
+7,598
| New | +$368K |
|
3333
Tredegar Corp
TG
$262M
| $341K | ﹤0.01% |
71,132
| – | – |
|
3334
Fennec Pharmaceuticals
FENC
$344M
| $339K | ﹤0.01% |
55,452
+13,955
| +34% | +$116K |
|
3335
Genmab
GMAB
$17.6B
| $338K | ﹤0.01% |
13,450
-13,830
| -51% | -$392K |
|
3336
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
| $336K | ﹤0.01% |
3,270
-3,027
| -48% | -$308K |
|
3337
Nerdy
NRDY
$107M
| $335K | ﹤0.01% |
200,518
+32,081
| +19% | +$70.5K |
|
3338
Core Molding Technologies
CMT
$200M
| $331K | ﹤0.01% |
20,759
+1,695
| +9% | +$31K |
|
3339
FibroBiologics
FBLG
$4.37M
| $331K | ﹤0.01% |
+3,314
| New | +$632K |
|
3340
INmune Bio
INMB
$47.1M
| $329K | ﹤0.01% |
+37,275
| New | +$367K |
|
|
SBT
3341
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $328K | ﹤0.01% |
62,641
+5,959
| +11% | +$29.4K |
|
|
PAMT
3342
PAMT Corp
PAMT
$347M
| $325K | ﹤0.01% |
18,739
+1,797
| +11% | +$29K |
|
3343
Porch Group
PRCH
$1.57B
| $325K | ﹤0.01% |
215,180
+182,180
| +552% | +$507K |
|
3344
Everspin Technologies
MRAM
$339M
| $325K | ﹤0.01% |
+54,229
| New | +$359K |
|
3345
NACCO Industries
NC
$356M
| $323K | ﹤0.01% |
11,674
| – | – |
|
3346
Ultralife
ULBI
$85.9M
| $323K | ﹤0.01% |
+30,387
| New | +$324K |
|
|
GPGI
3347
GPGI Inc
GPGI
$3.9B
| $322K | ﹤0.01% |
57,032
+5,426
| +11% | +$30K |
|
|
QIPT
3348
DELISTED
Quipt Home Medical
QIPT
| $322K | ﹤0.01% |
100,003
+9,186
| +10% | +$33K |
|
3349
Nautilus Biotechnolgy
NAUT
$131M
| $322K | ﹤0.01% |
137,487
+1,133
| +0.8% | +$2.96K |
|
3350
MediWound
MDWD
$181M
| $322K | ﹤0.01% |
+20,728
| New | +$343K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.